InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
T+90 hit rate
20%
T+90 mean return
-14.6%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by GRIFFIN MICHELLE RENEE. Director active across 2 companies, notably Adaptive Biotechnologies Corp. In total, 21 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €258k. Activity tracked since 18 May 2021. The latest transaction was filed on 13 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
52,084 sharesCommon StockSEC:0001229765-26-000008:0
52,084 sharesCommon StockSEC:0001229765-26-000008:1
36,291 shares@ US$7.1939.6% of flowCommon StockSEC:0001062993-25-005644:0
15,394 shares0Common StockSEC:0001062993-25-004800:0
31,328 shares0Common StockSEC:0001062993-24-005770:0
3,300 sharesCommon StockSEC:0001209191-23-045422:0
3,300 sharesCommon StockSEC:0001209191-23-033188:0
2,341 shares@ US$8.49133.0% of flowCommon StockSEC:0001062993-23-008033:0
14,775 shares0Common StockSEC:0001062993-23-006333:0
6,689 shares0Common StockSEC:0001209191-22-005497:0
6,689 shares0Common StockSEC:0001209191-22-005497
14,916 shares@ US$7.8016.3% of flowCommon StockSEC:0001209191-21-053971
14,916 shares@ US$7.800.0048% mcap28.5% of flowCommon StockSEC:0001209191-21-053971:0
2,500 shares@ US$7.802.7% of flowCommon StockSEC:0001209191-21-047303
2,500 shares@ US$7.800.0008% mcap4.7% of flowCommon StockSEC:0001209191-21-047303:0
4,000 shares@ US$7.804.3% of flowCommon StockSEC:0001209191-21-042289
4,000 shares@ US$7.800.0013% mcap7.5% of flowCommon StockSEC:0001209191-21-042289:0
2,500 shares@ US$7.802.7% of flowCommon StockSEC:0001209191-21-041089
2,500 shares@ US$7.800.0008% mcap4.6% of flowCommon StockSEC:0001209191-21-041089:0
2,500 shares@ US$7.804.6% of flowCommon StockSEC:0001209191-21-034235
2,500 shares@ US$7.800.0008% mcap4.6% of flowCommon StockSEC:0001209191-21-034235:0
21 of 21 declarations
About GRIFFIN MICHELLE RENEE
Michelle Renee Griffin is a director at Adaptive Biotechnologies Corp.
